CI Private Wealth »

Ernexa Therapeutics shares owned by CI Private Wealth

Quarter-by-quarter ownership of Ernexa Therapeutics (ERNA) shares owned by CI Private Wealth from 13F filings

Historical chart of CI Private Wealth investment in Ernexa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ernexa Therapeutics held by CI Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ernexa Therapeutics by CI Private Wealth

Quarter filed Position value Share count Share price at filing
2025-09-30 $480k 438k 1.10
2025-06-30 $32k 18k 1.84

More positions owned by CI Private Wealth

Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Meta Platforms Cl A (META)
Vanguard Index Fds Growth Etf (VUG)

View all positions for CI Private Wealth

Top funds holding Ernexa Therapeutics

CI Private Wealth
Susquehanna International
Geode Capital Management
Vanguard Group
Sippican Capital Adivsors
Tower Research Capital
BlackRock
Morgan Stanley
Assetmark
EverSource Wealth Advisors
Bnp Paribas Arbitrage, Snc
A. Montag and Associates
Activest Wealth Management

View all funds holding Ernexa Therapeutics